While the malaria death count in Cambodia dropped to just one case in 2016, a new threat to the race against the disease arises in south-eastern Asia: superbugs. A superbug is a drug-resistant, human-killing parasite that modern medicine struggles to combat.
I have just arrived (about 4 days ago) from a leadership course held at the Harvard Business School entitled Malaria: Science of Eradication. This course is a joint effort by Dr Dyann Wirth, Dr Pedro Alonso and Dr Marcel Tanner and is intended to be the first of many. The next course has already been allocated to Barcelona, home of Dr Pedro Alonso's ISGlobal.